Concepedia

Stuart Murray

SM

Statistics

Publications

10

Citations

1.6K

H-Index

10

Active since

2001

Affiliations

Agios Pharmaceuticals (United States)(Current)

Albert Einstein College of Medicine

Inserm

Harvard University

Institut Gustave Roussy

Stuart Murray is an author at Agios Pharmaceuticals (United States) specializing in life sciences, medicine, and molecular oncology.

Publications per year

2001–2019

10

Publications

10

Targeted Inhibition of Mutant IDH2 in Leukemia Cells Induces Cellular Differentiation

Fang Wang, Jeremy Travins, Byron DeLaBarre et al. · Science · 2013 · 797 citations

, , +10

mTORC1-dependent AMD1 regulation sustains polyamine metabolism in prostate cancer

Amaia Zabala‐Letona, Amaia Arruabarrena-Aristorena, Natalia Martín-Martín et al. · Nature · 2017 · 217 citations · Full text

, , +14

IDH2 mutation-induced histone and DNA hypermethylation is progressively reversed by small-molecule inhibition

Andrew Kernytsky, Fang Wang, Erica Hansen et al. · Blood · 2014 · 168 citations · Full text

, , +16

Phosphorylation of the RNA Polymerase II Carboxy-Terminal Domain by the Bur1 Cyclin-Dependent Kinase

Stuart Murray, Rajesh Udupa, Sheng Yao et al. · Molecular and Cellular Biology · 2001 · 100 citations · Full text

, , +16

PU.1 and pRB Interact and Cooperate To Repress GATA-1 and Block Erythroid Differentiation

Natasha Rekhtman, Kevin S. Choe, Igor Matushansky et al. · Molecular and Cellular Biology · 2003 · 100 citations · Full text

, , +15

1–5 of 10